Clinical Trial Update: An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

Phase 4 open-label study assessing aflibercept monotherapy for polypoidal choroidal vasculopathy, completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Age Related Macular Degeneration, Polypoidal Choroidal Vasculopathy | Phase 4 | Status: COMPLETED | Results posted: 2021-08-18